Epidemiology of Chronic Myeloid Leukemia in the Republic of Bashkortostan

Background. The planning of therapeutic, diagnostic, and preventive medical care for chronic myeloid leukemia (CML) patients implies the need of not only maintaining patient registries, but also conducting epidemiologic studies in each geographical area. Aim. To study and analyze CML epidemiologi...

Full description

Saved in:
Bibliographic Details
Main Authors: NR Ryabchikova, GSh Safuanova, VI Nikulicheva
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2018-10-01
Series:Клиническая онкогематология
Subjects:
Online Access:http://bloodjournal.ru/wp-content/uploads/2018/09/9-1.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850256328938749952
author NR Ryabchikova
GSh Safuanova
VI Nikulicheva
author_facet NR Ryabchikova
GSh Safuanova
VI Nikulicheva
author_sort NR Ryabchikova
collection DOAJ
description Background. The planning of therapeutic, diagnostic, and preventive medical care for chronic myeloid leukemia (CML) patients implies the need of not only maintaining patient registries, but also conducting epidemiologic studies in each geographical area. Aim. To study and analyze CML epidemiological indicators over the last 15 years in the Republic of Bashkortostan for the purposes of evaluation and rational planning of specialized medical care for CML patient population. Materials & Methods. The incidence, prevalence, and mortality of CML patients of all age groups in the period of 2000–2016 was analyzed in the Republic of Bashkortostan. Results. The analysis of epidemiological indicators over the period of 2000–2016 showed that the incidence of the disease in the Republic of Bashkortostan was increasing. Within the last 8 years the prevalence rate even quadrupled which is clearly connected with improved detectability of Ph-chromosome and/or BCR-ABL gene, creation and maintenance of CML patient registry since 2008, introduction of treatment using tyrosine kinase inhibitors resulting also in increase in life expectancy. Mortality rates are reported to have a tendency of decrease over the period under study. Conclusion. Key epidemiological indicators of CML in the Republic of Bashkortostan are comparable with the data of international and Russian researchers. The results obtained can be used for comparative studies and improvement of specialized medical care for CML patients.
format Article
id doaj-art-3919015b4f954e8da471de9b8f6ddb5d
institution OA Journals
issn 1997-6933
2500-2139
language Russian
publishDate 2018-10-01
publisher Practical Medicine Publishing House
record_format Article
series Клиническая онкогематология
spelling doaj-art-3919015b4f954e8da471de9b8f6ddb5d2025-08-20T01:56:39ZrusPractical Medicine Publishing HouseКлиническая онкогематология1997-69332500-21392018-10-0111434935310.21320/2500-2139-2018-11-4-349-353Epidemiology of Chronic Myeloid Leukemia in the Republic of BashkortostanNR Ryabchikova0GSh Safuanova1VI Nikulicheva2Bashkir State Medical University, 3 Lenina str., Ufa, Russian Federation, 450008Bashkir State Medical University, 3 Lenina str., Ufa, Russian Federation, 450008Bashkir State Medical University, 3 Lenina str., Ufa, Russian Federation, 450008Background. The planning of therapeutic, diagnostic, and preventive medical care for chronic myeloid leukemia (CML) patients implies the need of not only maintaining patient registries, but also conducting epidemiologic studies in each geographical area. Aim. To study and analyze CML epidemiological indicators over the last 15 years in the Republic of Bashkortostan for the purposes of evaluation and rational planning of specialized medical care for CML patient population. Materials & Methods. The incidence, prevalence, and mortality of CML patients of all age groups in the period of 2000–2016 was analyzed in the Republic of Bashkortostan. Results. The analysis of epidemiological indicators over the period of 2000–2016 showed that the incidence of the disease in the Republic of Bashkortostan was increasing. Within the last 8 years the prevalence rate even quadrupled which is clearly connected with improved detectability of Ph-chromosome and/or BCR-ABL gene, creation and maintenance of CML patient registry since 2008, introduction of treatment using tyrosine kinase inhibitors resulting also in increase in life expectancy. Mortality rates are reported to have a tendency of decrease over the period under study. Conclusion. Key epidemiological indicators of CML in the Republic of Bashkortostan are comparable with the data of international and Russian researchers. The results obtained can be used for comparative studies and improvement of specialized medical care for CML patients.http://bloodjournal.ru/wp-content/uploads/2018/09/9-1.pdfchronic myeloid leukemiaepidemiologyincidenceprevalencemortality
spellingShingle NR Ryabchikova
GSh Safuanova
VI Nikulicheva
Epidemiology of Chronic Myeloid Leukemia in the Republic of Bashkortostan
Клиническая онкогематология
chronic myeloid leukemia
epidemiology
incidence
prevalence
mortality
title Epidemiology of Chronic Myeloid Leukemia in the Republic of Bashkortostan
title_full Epidemiology of Chronic Myeloid Leukemia in the Republic of Bashkortostan
title_fullStr Epidemiology of Chronic Myeloid Leukemia in the Republic of Bashkortostan
title_full_unstemmed Epidemiology of Chronic Myeloid Leukemia in the Republic of Bashkortostan
title_short Epidemiology of Chronic Myeloid Leukemia in the Republic of Bashkortostan
title_sort epidemiology of chronic myeloid leukemia in the republic of bashkortostan
topic chronic myeloid leukemia
epidemiology
incidence
prevalence
mortality
url http://bloodjournal.ru/wp-content/uploads/2018/09/9-1.pdf
work_keys_str_mv AT nrryabchikova epidemiologyofchronicmyeloidleukemiaintherepublicofbashkortostan
AT gshsafuanova epidemiologyofchronicmyeloidleukemiaintherepublicofbashkortostan
AT vinikulicheva epidemiologyofchronicmyeloidleukemiaintherepublicofbashkortostan